2023 AAN Summer Conference Onsite Guide

IS IT LEMS OR MG?

Lambert-Eaton myasthenic syndrome (LEMS) and myasthenia gravis (MG) share several hallmark signs and symptoms, including muscle weakness and oculobulbar involvement 1,2

One way to differentiate these two immune-mediated neuromuscular disorders is to look for these specific signs and symptoms 1,2 :

LEMS MG

Symmetrical muscle weakness

Typically asymmetrical muscle weakness

Caudal-to-cranial pattern of spread

Late-onset and mild oculobulbar involvement

Absent or diminished tendon reflexes

Cranial-to-caudal pattern of spread

Early and prominent oculobulbar involvement

Preserved tendon reflexes

Autonomic dysfunction

Transient improvement of muscle strength with exercise, with fatigue that follows

Antibodies to voltage-gated calcium channels (VGCC) are usually found

No autonomic dysfunction

Muscle weakness worsens with exercise

Antibodies to AChR or MuSK are usually found

Quick Links

For handy access to most of the links mentioned below and to download your certificate of attendance, visit AAN.com/SCQuickLinks

WiFi

WiFi is available throughout the conference:

Audience Response

Network: Hyatt Meeting Space

Password: neurology

Some programs will seek input from participants in real time. Programs using this interactive feature are noted within the program’s schedule. To participate in audience response, visit AAN.cnf.io.

AAN Conferences Mobile App

Download the AAN Conferences mobile app at AAN.com/MobileApp and log in with your six-digit AAN ID and password to build your personalized schedule, get notification reminders throughout the conference, see program materials, claim CME, and more.

Livestreaming & Session Recordings

You can livestream and watch recordings of most sessions on the AAN Conferences mobile app or by visiting AAN.com/SCOnline. Log in with your six-digit AAN ID and password. Session recordings will be available approximately 24 hours after their originally scheduled time. You can access session recordings through August 14, with your registration. If you upgraded to On Demand, you’ll have access to session recordings in the Online Learning Center (learning.aan.com) from August 15-May 1, 2024.

Want to extend your access? Visit the registration desk or email aanscsupport@cmrus.com by August 14, 2023, and get up to 55% off

Program Materials

Slides and program materials are available online at AAN.com/Materials. Use your six-digit AAN ID and password to log in. Please note that availability of materials is at the discretion of the specific speaker. Not all sessions will have materials.

Claiming CME Credits

CME hours can be claimed by completing the program evaluation at AAN.com/SCCME by August 14 with Full Registration, or by May 1, 2024, with On Demand. Transcripts will be available upon evaluation submission. AAN members can also access their transcript via NeuroTracker™ at AAN.com/NeuroTracker

Lunch

Lunch is served in the Exhibit Hall daily from 11:30 a.m.–1:00 p.m.

Family & Prayer Room

A private room for nursing/pumping and/or praying is available for use during the conference. Visit Registration for access.

Exhibit Hall

Learn about the latest advancements in products and services enhancing the lives of neurology patients and their care providers.

Use your Exhibit Hall passport to visit a world of exhibitors and enter drawings to win prizes including Sonos wireless speaker and complimentary 2023 Fall Conference registration.

MEETING-AT-A-GLANCE

12:00 p.m.–2:00 p.m. Skills Building Session: Brain Death and the New Uniform Determination of Death Act (UDDA)

Skills Building Session: Burnout

Skills Building Session: Neurosonology: TCDs and Carotid Dopplers

Skills Building Session: Device Programming 101: Shunts/Deep Brain Stimulation

Skills Building Session: Point-of-Care EEG

SATURDAY, JULY 29

8:00 a.m.–11:00 a.m. Choose One: Track 1: Neurocritical Care, Part 1

Track 2: Hospital Neurology, Part 1

Track 3: Business/Training/ Education/DEI/Wellness, Part 1

11:00 a.m.–2:00 p.m Poster Session, Exhibit Hall, and Lunch

12:00 p.m.–2:00 p.m.

Skills Building Session: Brain Death and the New Uniform Determination of Death Act (UDDA)

Skills Building Session: Burnout

Skills Building Session: Neurosonology: TCDs and Carotid Dopplers

Skills Building Session: Device Programming 101: Shunts/Deep Brain Stimulation

Skills Building Session: Point-of-Care EEG

2:15 p.m.–4:45 p.m. Choose One:

Track 1: Neurocritical Care, Part 2

Track 2: Hospital Neurology, Part 2

Track 3: Business/Training/ Education/DEI/Wellness, Part 2

SCHEDULE

8:00 a.m.–11:00 a.m.

C1: Case-based Updates

Location: Nicollet Grand Ballroom BC

3

Learning Objectives: Participants should be able to describe guideline adherent care for patients with status epilepticus, acute ischemic stroke, intracerebral hemorrhage (ICH), and neuromuscular emergencies, and appreciate how recent clinical trials translate to bedside management; identify when these patients require specialized neuro-ICU level care and develop a framework for the most commonly encountered hospital complications; and become familiar with prognostication guidelines.

Lecture/Faculty:

8:00 a.m.–8:05 a.m.

» Welcome and Introduction

Casey S.W. Albin, MD, Atlanta, GA

Mark Milstein, MD, FAAN, Bronx, NY

8:05 a.m.–8:35 a.m.

» Status Epilepticus

Edilberto Amorim De Cerquiera Filho, MD, Quincy, MA

8:35 a.m.–9:05 a.m.

» Intracranial Hemorrhage

Claude Hemphill, III, MD, FAAN, San Francisco, CA

9:05 a.m.–9:35 a.m.

» Arterial Ischemic Stroke

Sharon Poisson, MD, Aurora, CO

9:35 a.m.–10:05 a.m.

» Neuromuscular Emergencies

Mark Anthony Terrelonge, Jr., MD, San Francisco, CA

10:05 a.m.–11:00 a.m.

» Health Disparities in Neurologic Emergencies and Inpatient Neurology

Starane Anthony Shepherd, MD, Atlanta, GA

11:00 a.m.–2:00 p.m.

Poster Session, Exhibit Hall, and Lunch

Location: Hyatt Exhibit Hall

FRIDAY, JULY 28

12:00 p.m.–2:00 p.m.

C2 : Skills Building Session: Brain Death and the New

Uniform Determination of Death Act (UDDA) 2

Location: Greenway Ballroom A

Learning Objectives: Participants should gain skills for brain death determination, with a focus on identifying appropriate patient for brain death testing; exam performance; and addressing ethical, legal, and moral dilemmas. If published by the time of the course, the session will include a review of the Uniform Determination of Death Act (UDDA) and how changes impact bedside practice.

Lecture/Faculty:

12:00 p.m.–12:05 p.m.

» Introduction

Matthew Kirschen, MD, PhD, FAAN, Philadelphia, PA

David M. Greer, MD, FAAN, Boston, MA 12:05 p.m.–12:50 p.m.

» Brain Death and the New Uniform Determination of Death Act (UDDA)

David M. Greer, MD, FAAN, Boston, MA

Matthew Kirschen, MD, PhD, FAAN, Philadelphia, PA 12:50 p.m.–1:15 p.m.

» Case Vignettes

David M. Greer, MD, FAAN, Boston, MA

Matthew Kirschen, MD, PhD, FAAN, Philadelphia, PA 1:15 p.m.–1:40 p.m.

» Difficult Conversations: Breaking the News

David M. Greer, MD, FAAN, Boston, MA

Matthew Kirschen, MD, PhD, FAAN, Philadelphia, PA 1:40 p.m.–2:00 p.m.

» Q&A

David M. Greer, MD, FAAN, Boston, MA

Matthew Kirschen, MD, PhD, FAAN, Philadelphia, PA

12:00 p.m.–2:00 p.m.

C3 : Skills Building Session: Burnout 2

Location: Greenway Ballroom B

Learning Objectives: Participants should develop the skills to recognize the symptoms of burnout and determine a comprehenisve and actionable plan to address symptoms and signs of burnout.

Lecture/Faculty:

12:00 p.m.–2:00 p.m.

» Skills Building Session: Burnout

Jennifer Bickel, MD, FAAN, Tampa, FL

12:00 p.m.–2:00 p.m.

: Skills Building Session: Neurosonology: TCDs and Carotid Dopplers 2

C4

Location: Greenway Ballroom J

Learning Objectives: In this case-based, small group focused session, participants will review the basics of transcranial Doppler (TCD) and carotid ultrasound, review normal anatomy and waveforms, apply knowledge to several cases to understand how neurosonography can change management in real time, and analyze waveforms and dicuss management changes based on findings.

Lecture/Faculty:

12:00 p.m.–12:05 p.m.

» Course Overview

Aaron M. Anderson, MD, Atlanta, GA

12:05 p.m.–12:20 p.m.

» Clinical Applications of TCDs

Aaron M. Anderson, MD, Atlanta, GA

Erika Sigman, MD, Atlanta, GA

12:20 p.m.–12:35 p.m.

» Live Demonstrations: Intracranial Vasculature

Anatomy and Introduction to Image Analysis

Aaron M. Anderson, MD, Atlanta, GA

Aarti Sarwal, MD, FAAN, Winston Salem, NC

Jimmy Suh, MD, Charleston, SC

Erika Sigman, MD, Atlanta, GA

12:35 p.m.–12:50 p.m.

» Introduction to Spectral Waveform Analysis and Interpretation

Aarti Sarwal, MD, FAAN, Winston Salem, NC

Jimmy Suh, MD, Charleston, SC

12:50 p.m.–1:05 p.m.

» Live Demonstration: High and Low Resistance Waveforms

Aarti Sarwal, MD, FAAN, Winston Salem, NC

Jimmy Suh, MD, Charleston, SC

Aaron M. Anderson, MD, Atlanta, GA

Erika Sigman, MD, Atlanta, GA

1:05 p.m.–1:55 p.m.

» Problem-based Learning: TCD Case Interpretation

Aarti Sarwal, MD, FAAN, Winston Salem, NC

Jimmy Suh, MD, Charleston, SC

Aaron M. Anderson, MD, Atlanta, GA

Erika Sigman, MD, Atlanta, GA

1:55 p.m.–2:00 p.m.

» Course Closeout

Aaron M. Anderson, MD, Atlanta, GA

Supporters: This program is supported in part by an educational grant, specifically in-kind support of medical equipment and supplies, from FUJIFILM Sonosite.The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.

12:00 p.m.–2:00 p.m.

C5 : Skills Building Session: Device Programming 101: Shunts/Deep Brain Stimulation

Location: Greenway Ballroom C

2

Learning Objectives: Through this session participants will become familiar with intracranial devices such as deep brain stimulators, external ventricular drains, and ventricle-peritoneal shunts. In the first hour common deep brain stimulator settings and troubleshooting is reviewed. In the second hour, CSF diversion strategies and common complications are presented. This session is geared to the consult neurologist and is applicable to all providers who work in a hospital setting.

Lecture/Faculty:

12:00 p.m.–1:00 p.m.

» Cerebrospinal Fluid Diversion

Paola Martinez, MD, San Antonio, TX

1:00 p.m.–2:00 p.m.

» Deep Brain Stimulation Management

Joan Miravite, DNP, RN,FNP-BC, FAAN, FAANP, New York, NY

Supporters: This program is supported in part by educational grants from Abbott Laboratories and Medtronic. The Academy was solely responsible, with no influence from the industry supporters, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporters with regard to this CME program.

SCHEDULE

12:00 p.m.–2:00 p.m.

C6 : Skills Building Session: Point of Care EEG

Location: Greenway Ballroom I

2

FRIDAY, JULY 28

2:15 p.m.–4:30 p.m.

C7: Inpatient Neurology

Location: Nicollet Grand Ballroom BC

2.25

Learning Objectives: In this small group, case-based session, participants should gain an understanding of how point-of-care EEG can be used to diagnose or rule out seizures and status epilepticus, and have the ability to practice putting on the headsets, visualizing different patterns on the bedside monitor and experience using the portal to understand the benefits and limitations of this new technology. Physicians with experience in using the device will be available for questions and answers.

Lecture/Faculty:

12:00 p.m.–2:00 p.m.

» Skills Building Session: Point of Care EEG

Parshaw Jonathan Dorriz, MD, Mission Viejo, CA

Supporters: This program is supported in part by an educational grant, specifically in-kind support of medical equipment and supplies, from Ceribell Point-of-Care EEG.The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.

2:00 p.m.–2:15 p.m.

Learning Objectives: Using interactive panel discussions and reflective presentations, participants should gain an appreciation for how to establish quality improvement initiatives for neuroinpatient and consult services, create a culture of wellness for both faculty and trainees, and reflect on ways to strengthen trainee engagement in learning while simultaneously building residents that are able to provide quality and consistent care at the bedside. There will be multiple panel sessions to facilitate discussion with questions and answers.

Lecture/Faculty:

2:15 p.m.–3:00 p.m.

» Developing a Quality Improvement Program in Inpatient Neurology: A Presentation and Panel Discussion

Karen Dianne Orjuela, MD, FAAN, Aurora, CO

Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA

3:00 p.m.–3:45 p.m.

» Wellness Among Inpatient Physicians and Trainees: Preventing and Treating Burnout

Mark Milstein, MD, FAAN, Bronx, NY

3:45 p.m.–4:30 p.m.

» Neurology Resident Inpatient Training 2023: Balancing Education with the Need to Care for Our Patients

Arielle Marisa Kurzweil, MD, FAAN, New York, NY

Raymond Price, MD, FAAN, Philadelphia, PA

4:00 p.m.–4:45 p.m.

Exhibit Hall Reception and Poster Session

Location: Hyatt Exhibit Hall

Exhibit Hall Reception sponsored by Alexion Pharmaceuticals Inc.

4:45 p.m.–5:45 p.m.

C8 : Challenging Cases in Hospital

Neurology and Neurocritical Care 1

Location: Nicollet Grand Ballroom BC

Learning Objectives: Through a case-based discussion, attendees will hear the approach of master clinicians to challenging cases in neurocritical care and hospital neurology, with a focus on clinical reasoning, diagnostic testing, management, and patient communication in the face of medical uncertainty. A wide variety of topics will be presented.

Lecture/Faculty:

4:45 p.m.–5:45 p.m.

» Challenging Cases in Hospital Neurology and Neurocritical Care

David M. Greer, MD, FAAN, Boston, MA

Karen Dianne Orjuela, MD, FAAN, Aurora, CO

Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA

John Probasco, MD, FAAN, Baltimore, MD

Emily Jean Gilmore, MD, New Haven, CT

SCHEDULE

8:00 a.m.–11:00 a.m.

C9 : Track 1: Neurocritical Care, Part 1 3

Location: Nicollet Grand Ballroom A

Learning Objectives: Participants will get a review on the approach and management to problems that are commonly encountered in patients admitted to the [neuro/surgical/ medical] ICU, making this session applicable to any neurologist who helps co-manage or consults on patients admitted in the ICU. Foundational skills like non-invasive monitoring, common NIR procedures and complications, and neuro-oncology medical and surgical emergencies will be reviewed through a case-based approach.

Lecture/Faculty:

8:00 a.m.–8:25 a.m.

» Non-invasive ICP Monitoring: Pupillometry, TCDs, and ONSD

Erika Sigman, MD, Atlanta, GA

8:25 a.m.–8:50 a.m.

» Critical Care/Anesthesia 101 for Neurologists

Starane Anthony Shepherd, MD, Atlanta, GA

8:50 a.m.–9:15 a.m.

» Neurosurgical Oncology for the Neurohospitalist

Nader Sanai, MD, Phoenix, AZ

9:15 a.m.–9:40 a.m.

» NIR 1: Nuts and Bolts of Thrombectomy, Rescue Stenting, and Groin Complications

Robert W. Regenhardt, MD, PhD, Boston, MA

9:40 a.m.–10:05 a.m.

» NIR 2: Emerging Neuro-endovascular Treatments: MMA, Embolization, Stenting PT/ IIH, and Shunting

Thabele M. Leslie-Mazwi, MD, Seattle, WA

10:05 a.m.–10:25 a.m.

» Neuro-oncology Emergencies

Brian Scott, MD, San Francisco, CA

10:25 a.m.–10:45 a.m.

» Pain and Headache Management

Kaitlin Johanna Reilly-Kit, MD, Hackensack, NJ

10:45 a.m.–10:50 a.m.

» Discrepancies Between Neuroprognostication Assessments and End-of-Life Decision-Making in Post-Cardiac Arrest Patients

Rebecca Stafford, Boston, MA

10:50 a.m.–10:55 a.m.

» A Prospective Study of Optimal Dosing Strategies of Levetiracetam for Seizure

Prophylaxis in Critically Ill Patients

Eduard Humberto Valdes, MD, NY, NY

10:55 a.m.–11:00 a.m.

» Microvascular Cerebral Blood Flow Monitoring Detects Response to Intrathecal Nicardipine Treatment for Vasospasm

Erika Sigman, MD, Atlanta, GA

8:00 a.m.–11:00 a.m.

C10 : Track 2: Hospital Neurology, Part 1 3

Location: Nicollet Grand Ballroom BC

Learning Objectives: Participants should learn about commonly and less commonly encountered consult questions, and a case-based approach will be used to provide a framework for the work-up and management of these issues. Special emphasis will be placed on selected patient populations such as pregnant women and immunocompromised patients.

Lecture/Faculty:

8:00 a.m.–8:35 a.m.

» Neuro-obstetrics Management and Emergencies

Mary Angela O’Neal, MD, FAAN, Boston, MA

8:35 a.m.–9:10 a.m.

» Women’s Issues Pertaining to the Neurohospitalist

Sara LaHue, MD, San Francisco, CA

9:10 a.m.–9:45 a.m.

» Neuroinfectious Emergencies in the Hospital

Felicia Chow, MD, San Francisco, CA

9:45 a.m.–10:20 a.m.

» Headaches in the Emergency Department

Crystal Jicha, MD, Orange, CA

10:20 a.m.–10:45 a.m.

» Neurologic Complications of COVID in the Hospital

Sherry Chou, MD, Chicago, IL

10:45 a.m.–10:50 a.m.

» Financial Burden of Multiple Sclerosis

Hospitalizations; A National Study during 20092019 in the United States

Sepideh Yadollahi, MD, Irvine, CA

10:50 a.m.–10:55 a.m.

» Indications and Outcomes of Carotid Artery

Stenting among Consecutive Patients over Age 70 at The Ottawa Hospital, a Comprehensive Stroke Centre in Ontario, Canada

Kyra Rose Steiner, Ottawa, ON, Canada

8:00 a.m.–11:15 a.m.

C11: Track 3: Business/Training/ Education/DEI/Wellness, Part 1

Location: Nicollet Grand Ballroom D

3.25

Learning Objectives: Participants should learn about common operational, administrative, and educational challenges for inpatient neurology; analyze challenges with quality and safety leaders; and use a case-based approach to improve teaching at the bedside. Throughout the session, there will be a focus on communication skills with administrators, colleagues, students, and patients.

Lecture/Faculty:

8:00 a.m.–8:30 a.m.

» Neuro-prognostication: A Framework Approach

David J. Fischer, MD, Philadelphia, PA

8:30 a.m.–9:15 a.m.

» Starting a Neurohospitalist Service at an Academic Medical Center

Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA

John Probasco, MD, FAAN, Baltimore, MD

Kathryn Kvam, MD, Stanford, CA

9:15 a.m.–9:45 a.m.

» Bedside Teaching Tips and Tricks

Aaron L. Berkowitz, MD, PhD, FAAN, San Francisco, CA

9:45 a.m.–10:15 a.m.

» A Comprehensive Delirium Reduction and Prevention Program

Sara LaHue, MD, San Francisco, CA

10:15 a.m.–10:45 a.m.

» Challenging Cases in Neuroimaging

Joshua P. Klein, MD, PhD, FANA, FAAN, Boston, MA

10:45 a.m.–11:15 a.m.

» Diagnostic Reasoning in Challenging Cases

Aaron L. Berkowitz, MD, PhD, FAAN, San Francisco, CA

11:00 a.m.–2:00 p.m.

Poster Session, Exhibit Hall, and Lunch

Location: Hyatt Exhibit Hall

12:00 p.m.–2:00 p.m.

C12 : Skills Building Session: Brain Death and the New Uniform Determination of Death Act (UDDA) 2

Location: Greenway Ballroom A

Learning Objectives: Participants should gain skills for brain death determination, with a focus on identifying appropriate patient for brain death testing; exam performance; and addressing ethical, legal, and moral dilemmas. If published by the time of the course, the session will include a review of the Uniform Determination of Death Act (UDDA) and how changes impact bedside practice.

Lecture/Faculty:

12:00 p.m.–12:05 p.m.

» Introduction

Matthew Kirschen, MD, PhD, FAAN, Philadelphia, PA

David M. Greer, MD, FAAN, Boston, MA

12:05 p.m.–12:50 p.m.

» Skills Building Session: Brain Death and the New Uniform Determination of Death Act (UDDA)

David M. Greer, MD, FAAN, Boston, MA

Matthew Kirschen, MD, PhD, FAAN, Philadelphia, PA

12:50 p.m.–1:15 p.m.

» Case Vignettes

David M. Greer, MD, FAAN, Boston, MA

Matthew Kirschen, MD, PhD, FAAN, Philadelphia, PA 1:15 p.m.–1:40 p.m.

» Difficult Conversations: Breaking the News

David M. Greer, MD, FAAN, Boston, MA

Matthew Kirschen, MD, PhD, FAAN, Philadelphia, PA 1:40 p.m.–2:00 p.m.

» Q&A

David M. Greer, MD, FAAN, Boston, MA

Matthew Kirschen, MD, PhD, FAAN, Philadelphia, PA

12:00 p.m.–2:00 p.m.

C13 : Skills Building Session: Burnout 2

Location: Greenway Ballroom B

Learning Objectives: Participants should develop the skills to recognize the symptoms of burnout and determine a comprehensive and actionable plan to address symptoms and signs of burnout.

Lecture/Faculty: 12:00 p.m.–2:00 p.m.

» Skills Building Session: Burnout

Jennifer Bickel, MD, FAAN, Tampa, FL

SCHEDULE

12:00 p.m.–2:00 p.m.

C14 : Skills Building Session:

Neurosonology: TCDs and Carotid Dopplers 2

Location: Greenway Ballroom J

Learning Objectives: In this case-based, small group focused session, participants will review the basics of Transcranial Doppler (TCD) and carotid ultrasound; review anatomy and waveforms; apply knowledge to several cases to understand how neurosonography can change management in real time; and analyze waveforms and dicuss management changes based on findings.

Lecture/Faculty:

12:00 p.m.–12:05 p.m.

» Course Overview

Aaron M. Anderson, MD, Atlanta, GA

12:05 p.m.–12:20 p.m.

» Clinical Applications of TCDs

Aaron M. Anderson, MD, Atlanta, GA

Erika Sigman, MD, Atlanta, GA

12:20 p.m.–12:35 p.m.

» Live Demonstrations: Intracranial Vasculature

Anatomy and Introduction to Image Analysis

Aaron M. Anderson, MD, Atlanta, GA

Aarti Sarwal, MD, FAAN, Winston Salem, NC

Jimmy Suh, MD, Charleston, SC

Erika Sigman, MD, Atlanta, GA

12:35 p.m.–12:50 p.m.

» Introduction to Spectral Waveform Analysis and Interpretation

Aarti Sarwal, MD, FAAN, Winston Salem, NC

Jimmy Suh, MD, Charleston, SC

12:50 p.m.–1:05 p.m.

» Live Demonstration: High and Low Resistance Waveforms

Aarti Sarwal, MD, FAAN, Winston Salem, NC

Jimmy Suh, MD, Charleston, SC

Aaron M. Anderson, MD, Atlanta, GA

Erika Sigman, MD, Atlanta, GA

1:05 p.m.–1:55 p.m.

» Problem-based Learning: TCD Case Interpretation

Aarti Sarwal, MD, FAAN, Winston Salem, NC

Jimmy Suh, MD, Charleston, SC

Aaron M. Anderson, MD, Atlanta, GA

Erika Sigman, MD, Atlanta, GA

1:55 p.m.–2:00 p.m.

» Course Closeout

Aaron M. Anderson, MD, Atlanta, GA

Supporters: This program is supported in part by an educational grant, specifically in-kind support of medical equipment and supplies, from FUJIFILM Sonosite. The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.

12:00 p.m.–2:00 p.m.

C15 : Skills Building Session: Device Programming 101: Shunts/ Deep Brain Stimulation

Location: Greenway Ballroom C

2

Learning Objectives: Participants should become familiar with intracranial devices such as deep brain stimulators, external ventricular drains, and ventricle-peritoneal shunts; common deep brain stimulator settings and troubleshooting; and CSF diversion strategies and common complications. This session is geared to the consult neurologist and is applicable to all providers who work in a hospital setting.

Lecture/Faculty:

12:00 p.m.–1:00 p.m.

» Cerebrospinal Fluid Diversion

Paola Martinez, MD, San Antonio, TX

1:00 p.m.–2:00 p.m.

» Deep Brain Stimulation Management

Joan Miravite, DNP, RN,FNP-BC, FAAN, FAANP, New York, NY

Supporters: This program is supported in part by educational grants from Abbott Laboratories and Medtronic.The Academy was solely responsible, with no influence from the industry supporters, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporters with regard to this CME program.

12:00 p.m.–2:00 p.m.

C16 : Skills Building Session: Point of Care EEG 2

Location: Greenway Ballroom I

Learning Objectives: In this small group, case-based session, participants should gain an understanding of how Point-of-Care EEG can be used to diagnose or rule out seizures and status epilepticus, and be able to practice putting on the headsets, visualizing different patterns on the bedside monitor and experience using the portal to understand the benefits and limitations of this new technology. Physicians with experience in using the device will be available for questions and answers.

Lecture/Faculty:

12:00 p.m.–2:00 p.m.

» Skills Building Session: Point-of-care EEG

Parshaw Jonathan Dorriz, MD, Mission Viejo, CA

Supporters: This program is supported in part by an educational grant, specifically in-kind support of medical equipment and supplies, from Ceribell Point-of-Care EEG.The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.

2:00 p.m.–2:15 p.m. Break

2:15 p.m.–4:45 p.m.

C17: Track 1: Neurocritical Care, Part 2 2.5

Location: Nicollet Grand Ballroom A

Learning Objectives: Using a case-based approach, participants will analyze commonly encountered neurologic emergencies in consult neurology. This session will focus on evidencebased updates as well as practical pearls for bedside management.

Lecture/Faculty:

2:15 p.m.–2:45 p.m.

» Cases and Challenges in ICP Management

Nicholas Allen Morris, MD, Baltimore, MD

2:45 p.m.–3:15 p.m.

» Cases and Challenges in Post Cardiac Arrest Management

Alexis Madeline Steinberg, MD, Pittsburgh, PA

3:15 p.m.–3:45 p.m.

» Considerations for Safe Transport by Ground of Neurocritically Ill Patients

Neha Dangayach, MD, FAAN, New York, NY

3:45 p.m.–4:15 p.m.

» Considerations for Safe Transport by Air of Neurocritically Ill Patients

Vasisht Srinivasan, MD, Seattle, WA

4:15 p.m.–4:45 p.m.

» A Case-based Update in the Role of cEEG

Edilberto Amorim De Cerquiera Filho, MD, Quincy, MA

2:15 p.m.–4:45 p.m.

C18 : Track 2: Hospital Neurology, Part 2 2.5

Location: Nicollet Grand Ballroom BC

Learning Objectives: Using a case-based approach and didactic-style review of evidence, experts in neuro-ophthalmology, neuropalliative care, and autoimmune neurology discuss practical pearls for neurologists seeing hospitalized patients. This session will help attendees create a framework for approaching challenging and often perplexing patients.

Lecture/Faculty:

2:15 p.m.–2:45 p.m.

» Inpatient Neuro-ophthalmology

Nancy J. Newman, MD, FAAN, Atlanta, GA

2:45 p.m.–3:15 p.m.

» The Role of Neuropalliative Care

Caroline Crooms, MD, New York, NY

3:15 p.m.–3:45 p.m.

» Rapidly Progressive Dementia

Michael D. Geschwind, MD, PhD, FAAN, San Francisco, CA

3:45 p.m.–4:15 p.m.

» Infectious Encephalitis: The Real Deal and Mimics

Michel Toledano, MD, Rochester, MN

4:15 p.m.–4:45 p.m.

» An Update in CNS Autoimmune Conditions

Marcelo Matiello, MD, Boston, MA

2:15 p.m.–4:45 p.m.

C19 : Track 3: Business/Training/ Education/DEI/Wellness, Part 2 2.5

Location: Nicollet Grand Ballroom D

Learning Objectives: For practicing neurologists who are interested in integrating services and providing high-value care, experts in this session will discuss navigating challenges in academic services and how to build a telestroke program, as well as how to use implementation science and the electronic health record to improve quality of care. Practical considerations like how to adroitly integrate APPs will also be discussed.

Lecture/Faculty:

2:15 p.m.–2:45 p.m.

» Operational Challenges in Academic Services

Marcelo Matiello, MD, Boston, MA

2:45 p.m.–3:15 p.m.

» Integrating Advance Practice Providers into Inpatient Neurology: A Panel Discussion

Jana Wold, MD, Salt Lake City, UT

Allyson Hamacher, PA, Phoenix, AZ

Peter Reuter, NP, Rochester, MN

3:15 p.m.–3:45 p.m.

» Building a Telestroke Program

Alicia Zha, MD, Columbus, OH

3:45 p.m.–4:15 p.m.

» Using Implementation Science to Improve Value in Inpatient Neurology

Mona Bahouth, MD, Baltimore, MD

4:15 p.m.–4:45 p.m.

» Use the Electronic Health Record on Daily Rounds for Inpatient Neuro Quality Metrics

Allison L. Weathers, MD, FAAN, Chagrin Falls, OH

POSTERS

All posters will be available in person and online throughout the conference. The poster hall is open:

Friday, July 28: 11:00 a.m.–2:00 p.m. 4:00 p.m.–4:45 p.m.

Saturday, July 29: 11:00 a.m.–2:00 p.m.

Authors will stand by their posters from 11:00 a.m. to 12:00 p.m. each day. Posters will be available on the mobile app and online platform through August 14, 2023.

Neurocritical Care

Poster No. Title

1 Effect of SARS-CoV-2 Pandemic on Trends in Stroke Hospitalizations and Associated Risk Factors in NonSARS-CoV-2 Infection Patients

2 Acute Neurological Emergencies: Using NeurologyTrained Standardized Patients To Promote Active Learning in a Case-Based Simulation Curriculum for Neurology Clerkship Students

3 Tenecteplase Versus Alteplase for Acute Ischemic Stroke in a Community Hospital Setting

4 LACE+ is marginally predictive of 30-day readmission after stroke

5 A Meta-Analysis on the Neurovascular Complications Of Extracorporeal Membrane Oxygenation In Critically Ill COVID-19 Patients

Presenter

Nabeel Ahmed

Casey S.W. Albin, MD

Latha Ganti, MD, MS, MBA, FACEP

Muhib Khan, MD, FAAN

Carol Li

MBBS

Mohammad Ali Shahab, MD, MBBS

Poster No. Title

13 Microvascular Cerebral Blood Flow Monitoring Detects Response to Intrathecal Nicardipine Treatment for Vasospasm

14 Discrepancies Between Neuroprognostication Assessments and End-of-Life Decision-Making in PostCardiac Arrest Patients

15 T-wave Heterogeneity is Superior to QTc in 12-Lead ECG in Detection of Cardiac Electrical Instability at EMU Admission

16 A Prospective Study of Optimal Dosing Strategies of Levetiracetam for Seizure Prophylaxis in Critically Ill Patients

17 Data in brief: Factors associated with in-patient admission among stroke patients

18 Financial Burden of Multiple Sclerosis Hospitalizations; A National Study during 2009-2019 in the United States

19 Indications and Outcomes of Carotid Artery Stenting among Consecutive Patients over Age 70 at The Ottawa Hospital, a Comprehensive Stroke Centre in Ontario, Canada

20 Patient-reported outcomes in the Telehealth After Stroke Care feasibility randomized clinical trial: home blood pressure telemonitoring-enhanced versus usual postacute stroke care in an underserved setting

Presenter

Jared Craig Wolfe

Erika Sigman, MD

Rebecca Stafford

Anthony Phan Tran, MD

Eduard Humberto Valdes, MD

Sepideh Yadollahi, MD

Kyra Rose Steiner

Imama Ali Naqvi, MD

EXHIBITORS

American Brain Foundation

Booth 22

americanbrainfoundation.org/ngrg

Stop by the American Brain Foundation booth to purchase a t-shirt and other exclusive items, learn about grant opportunities for 2024, or make a donation to support the critical need for research funding. Founded by the American Academy of Neurology, the American Brain Foundation has been investing in research for improved prevention, treatment, and cures for neurologic diseases and disorders for over 30 years. Meet our current class of researchers at americanbrainfoundation.org/ngrg.

Access TeleCare

Booth 8

accesstelecare.com

We start with the medicine. We start with our physicians. With our network of more than 600 specialists and subspecialists from some of the nation’s most esteemed health care systems and academic medical centers, every hospital in every community can give its patients worldclass care. We facilitate that care with our technology. Our telemedicine carts are designed by physicians who understand how powerful technology can be but also how it can obstruct and frustrate if not done well. And, we support that care by working with hospitals to make it financially sustainable.

Alexion

Booth 5

alexion.com

Alexion is a global biopharmaceutical company with the mission of transforming the lives of people affected by rare diseases by continuously innovating and creating meaningful value in all that we do. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Altus Biologics

Booth 17

altusbiologics.com

About us, Altus Biologics, In-Office Biologic Therapy Management Solutions. Since 2010, Altus Biologics has been partnering with physicians to provide comprehensive infusion therapy services in their offices, ensuring the best standard of care at the point of service to patients. In-office infusion therapy allows patients to receive their treatment in a comfortable, convenient, and familiar environment under the supervision of their trusted healthcare team. Healthcare providers benefit from increased patient management, interaction, and education — all of which can strengthen the provider-patient relationship and patient outcomes.

argenx

Booth 15

argenx.com

argenx is a global immunology company developing antibody-based medicines for patients suffering from severe autoimmune diseases and cancer. By translating immunology breakthroughs into innovative drug candidates, argenx is building a world-class portfolio of first-in-class antibodies in both early and late clinical-stages of development.

Brain PAC/Advocacy

Booth 21

aan.com/advocacy/brainpac

BrainPAC is the political action committee (PAC) of the American Academy of Neurology, and the only federal political action committee in Washington, DC, that specifically represents the profession of neurology. It gives the AAN a strong voice on Capitol Hill and exists to support and help elect neurology-friendly candidates to the U.S. Congress. Personal contributions to BrainPAC help us advocate for AAN priorities. BrainPAC is a nonpartisan PAC and contributes to both Democrats and Republicans who support our issues.

Catalyst Pharmaceuticals

Booth 4

catalystpharma.com

With exceptional patient focus, Catalyst is committed to developing and commercializing innovative first-in-class medicines that address rare neurological and epileptic diseases. Catalyst’s U.S. commercial product portfolio consists of FIRDAPSE® (amifampridine) Tablets 10 mg, approved for the treatment of LambertEaton myasthenic syndrome (“LEMS”) for adults and children ages six to seventeen. In January 2023, Catalyst acquired the U.S. commercial rights of FYCOMPA® (perampanel) CIII, a prescription medicine approved in people with epilepsy aged four and older alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures, and with other medicines to treat primary generalized tonic-clonic seizures for people with epilepsy aged 12 and older. Further, Canada’s national healthcare regulatory agency, Health Canada, has approved the use of FIRDAPSE for the treatment of adult patients in Canada with LEMS.

DiaMedica

Booth 1

diamedica.com

DiaMedica is in a pivotal Phase 2b/3 for DM199, a recombinant KLK1 protein, for the treatment of acute ischemic stroke. DM199 is believed to improve collateral circulation in the ischemic penumbra.

Genentech

Booth 6

gene.com

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or lifethreatening medical conditions. Today, we are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline.

Horizon Therapeutics

Booth 7

Booth 9

camc.org

CAMC is a nonprofit, 1,103-bed regional referral center made up of six hospitals: CAMC General Hospital, CAMC Greenbrier Valley Medical Center, CAMC Memorial Hospital, CAMC Plateau Medical Center, CAMC Teays Valley Hospital and CAMC Women and Children’s Hospital, as well as the CAMC Institute for Academic Medicine and the CAMC Foundation. Nearly 900 physicians have admitting privileges at CAMC, which is also West Virginia’s premiere medical teaching facility, hosting, on any given day, more than 800 students in programs leading to degrees or certifications in health professions. CAMC started a Neurology Residency Program July 1, 2023.

horizontherapeutics.com

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.

Charleston Area Medical Center

EXHIBITORS

Membership and Career Center

Booth 20

careers.aan.com & aan.com/membership

The Neurology Career Center is the world’s largest neurology-focused career resource.  Stop by the booth to view available jobs, observe demos, and pick up a copy of the July Career Compass job guide and other gifts.

Pfizer Inc. (Pfizer Hospital Internal Medicine)

Booth 13

pfizer.com

About Pfizer: Breakthroughs That Change

Patients’ Lives. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.

Pfizer US Neuroscience Division

Booth 11

pfizer.com

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value the discovery, development, and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer products.  Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.

RosmanSearch, Inc.

Booth 10

rosmansearch.com

RosmanSearch is a Neurosurgery, Neurology and APP recruitment firm. We place quality providers with quality practices nationwide. We are the only search firm with dedicated teams specializing in neuroscience. Our mission is to be the best, the most expert, and the one that is known for quality—every time!

Ultragenyx

Booth 3

ultragenyx.com

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultrarare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon timeand cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. For more information on Ultragenyx, please visit the company’s website at: www.ultragenyx.com.

University of Minnesota

Booth 12

med.umn.edu/neurology

The Department of Neurology at the University of Minnesota and UMPhysicians is actively recruiting to grow our Neurology team of nearly 50 clinical faculty in 10 subspecialties.

Variantyx Inc.

Booth 14

variantyx.com

Variantyx is a technology-driven precision medicine company providing state-of-theart diagnostic solutions for the rare genetic disorders and reproductive genetics markets, and treatment optimization in oncology.

Our proprietary whole genome analysis platform allows us to better understand a person’s genetic makeup, leading to unmatched diagnostic capabilities and improved personalized treatment recommendations.

Wolters Kluwer

Booth 2

lww.com

Wolters Kluwer Health is a global provider of information, business intelligence and pointof-care solutions for the healthcare industry . Brands include Lippincott Williams & Wilkins, a leading international publisher of medical books, electronic media and journals and the official publisher of American Academy of Neurology. We proudly offer specialized publications and software for physicians, nurses, students and clinicians. Please visit our booth to browse our comprehensive product line.

Zeto

Booth 16

zeto-inc.com

Zeto is changing the way Routine EEG is done at hospitals. ‘Fast, convenient, medical-grade EEG’, is what we do. Our product is the first FDA cleared dry electrode EEG headset and software platform. Patent pending, zero-prep and easy to wear headset with electrodes placed as per the 10-20 EEG system backed by a cloud platform that offers instant upload, tools for analysis and live viewing from any location. Zeto also makes EEG available to facilities that currently do not have access to it.

CONFERENCE GUIDELINES & POLICIES

The following are guidelines for AAN conferences. Unless specified, these guidelines apply to all AAN conference formats. In addition to the below guidelines, participation in an in-person or online AAN meeting is subject to AAN’s Privacy Policy (AAN.com/PrivacyPolicy). All individuals engaged in any in-person or online meeting are subject to the AAN.com Code of Conduct (AAN.com/Conduct), unless otherwise specifically noted. Use of the website and online program site(s) is subject to AAN’s Terms of Use (AAN.com/TermsofUse). These conference policies are subject to change without notice, at AAN’s discretion. Any changes will be reflected on AAN.com/ConfGuidelines.

ACCME Accreditation

The American Academy of Neurology Institute (AANI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation

The American Academy of Neurology Institute (AANI), a subsidiary of the AAN, designates this live/enduring activity for a maximum of (*) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*See individual program descriptions for the maximum number of credits per program.

ABPN Statement

The American Board of Psychiatry and Neurology has reviewed the relevant AAN conference and has approved the program as a part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of continuing certification.

Commitment to Inclusion, Diversity, Equity, Anti-racism, and Social Justice (IDEAS)

The AAN is committed to intentional actions to be a fully inclusive, deliberately diverse, and anti-racist organization that respects and values our membership, our staff, and the communities we serve. We actively promote equity and social justice in neurology and the neurosciences. As part of this commitment, the AAN is working to ensure we provide a conference environment and educational programming that is fully inclusive, deliberately diverse, and anti-racist. If you have questions about these efforts, identify areas for improvement, or have concerns regarding attendee or staff behavior, please contact Member Services at (800) 879-1960, memberservices@aan.com, or conference staff at registration@aan.com

Professional Conduct and Anti-harassment

The AAN expects all meeting participants, including attendees, members, speakers, staff, contractors, vendors, and exhibitors, to behave respectfully, responsibly, and professionally towards each other, and to abide by the AAN’s Meetings Anti-Harassment Policy during the conference. The AAN is committed to providing a conference environment that is free from all forms of discrimination and harassment. Violations of this policy may be reported to Member Services at (800) 879-1960, memberservices@aan.com, or to conference staff at registration@aan.com

Authorization for Use of Image, Name, and Other Likeness

By attending the AAN meeting or logging into the meeting’s website(s) or application(s) and engaging in any activities or interactive features, you agree that AAANI and/or third parties authorized by AAANI may photograph or record your likeness, image, name, voice, and/or words, and may publish, display, reproduce, copy, and distribute your likeness, image, name, voice, and/or words for promotional, educational, or membership activities worldwide in all forms of media now known or later developed, including but not limited to advertising, training, websites, presentations, and marketing materials. You further acknowledge that AAANI and/or third parties authorized by AAANI have the right, but not the obligation, to identify you in connection with such media by name and/or affiliation. No royalties will be payable in connection with this authorization or these uses.

Social Media

The American Academy of Neurology (AAN) encourages all AAN conference attendees to share their experience on social media using the official conference hashtag (#AANSC). When doing so, please adhere to the following AAN Meetings Social Media Policies:

• Photography and screenshots of presentations are permitted for personal use only. Photography or screenshots for commercial use are strictly prohibited.*

• Do not disrupt fellow attendees.

• Do not post any information or other material protected by copyright without the permission of the copyright owner.

• Do not post confidential or identifiable patient information.

• Do not post any material that is defamatory, abusive, profane, threatening, offensive, illegal, or violates any third party’s rights.

• Videography, including live streaming, is strictly prohibited regardless of intended use.

• Usage of the AAN logo or an AAN conference logo on social media is prohibited.

The AAN has the right to ask any AAN conference attendee to remove a social post or to stop taking photos or recording video at any time.